Kaplan–Meier DSS analysis showed that high expression of HNRNPA2B1 was a risk factor for patients with ACC, GBMLGG, KICH, LUAD, LIHC, LGG, PRAD, and SARC. Here, HNRNPA2B1 is linked to adrenal cortex carcinoma.